Glory Health Industry Ltd. reported its interim results for the six months ended June 30, 2025. The company achieved contracted sales of RMB651.1 million during the period. However, the revenue from property development was reported at RMB182.7 million, indicating a decline from previous figures due to market pressures in the rental sector. Overall, the group's revenue amounted to RMB324.2 million, which is a significant decrease compared to the RMB987.5 million reported in the same period of 2024. The company's gross profit was RMB4.4 million, while it recorded a net loss of RMB170.0 million. The company also announced a strategic shift, planning to transition into the health industry, tapping into its broad market potential. This move signifies a strategic pivot amid a complex market environment. The company's land reserves reached a total gross floor area of 6,387,065 square meters, with 54% of the saleable land reserve located in Beijing.